Citi Pharma Ltd.

48
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PK0126201018
PKR
85.11
-3.06 (-3.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Jun'25
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
No of Months
12
12
12
12
12
12
Operating Income
13,153.00
12,409.00
12,396.00
9,779.00
5,795.00
3,527.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
13,153.00
12,409.00
12,396.00
9,779.00
5,795.00
3,527.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
631.00
553.00
453.00
340.00
248.00
169.00
Operating Expenses
323.00
299.00
140.00
64.00
40.00
43.00
General and Administration Expenses
381.00
358.00
320.00
356.00
198.00
171.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
11,621.00
11,270.00
11,286.00
8,851.00
5,251.00
3,284.00
Operating Profit (PBDIT) excl Other Income
1,531.00
1,138.00
1,110.00
928.00
544.00
243.00
Other Income
173.00
438.00
23.00
221.00
4.00
7.00
Operating Profit (PBDIT)
1,846.00
1,686.00
1,206.00
1,206.00
606.00
298.00
Interest
323.00
299.00
140.00
64.00
40.00
43.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
168.00
138.00
90.00
76.00
65.00
52.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,354.00
1,277.00
955.00
1,060.00
499.00
202.00
Provision for Tax
462.00
444.00
297.00
406.00
147.00
59.00
Profit After Tax
892.00
833.00
657.00
653.00
351.00
143.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
3.90
3.65
2.88
2.88
2.15
28.97
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Jun 2025 is 6.00% vs 0.10% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Jun 2025 is 34.50% vs 2.54% in Jun 2024

stock-summary

Interest

YoY Growth in year ended Jun 2025 is 7.91% vs 113.38% in Jun 2024

stock-summary

Profit After Tax

YoY Growth in year ended Jun 2025 is 7.03% vs 26.67% in Jun 2024

Compare Profit and Loss Results of Citi Pharma Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(PKR)
Change(%)
No of Months
12
12
Operating Income
13,153.00
18,856.00
-5,703.00
-30.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
13,153.00
18,856.00
-5,703.00
-30.25%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
631.00
3,390.00
-2,759.00
-81.39%
Operating Expenses
323.00
568.00
-245.00
-43.13%
General and Administration Expenses
381.00
5,638.00
-5,257.00
-93.24%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
11,621.00
16,866.00
-5,245.00
-31.10%
Operating Profit (PBDIT) excl Other Income
1,531.00
1,989.00
-458.00
-23.03%
Other Income
173.00
164.00
9.00
5.49%
Operating Profit (PBDIT)
1,846.00
3,017.00
-1,171.00
-38.81%
Interest
323.00
568.00
-245.00
-43.13%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
168.00
934.00
-766.00
-82.01%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,354.00
1,525.00
-171.00
-11.21%
Provision for Tax
462.00
603.00
-141.00
-23.38%
Profit After Tax
892.00
776.00
116.00
14.95%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
3.9046
17.8642
-13.96
-78.14%
Profit And Loss - Net Sales
Net Sales 13,153.52 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is 6.00% vs 0.10% in Jun 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,531.98 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is 34.50% vs 2.54% in Jun 2024

Profit And Loss - Interest
Interest 323.63 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is 7.91% vs 113.38% in Jun 2024

Profit And Loss - Profit After Tax
Profit After Tax 892.04 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is 7.03% vs 26.67% in Jun 2024